2012
DOI: 10.1016/j.gene.2012.04.084
|View full text |Cite
|
Sign up to set email alerts
|

Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
2
4

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(19 citation statements)
references
References 89 publications
0
13
2
4
Order By: Relevance
“…BCL2L12 is one of the most recently identified genes of this family, whose role in apoptosis has not been fully defined yet [35]. Although BCL2L12 expression has been found to be significantly affected by several antineoplastic drugs [36], in our experiments no remarkable alterations were noticed in its mRNA levels.…”
Section: Discussioncontrasting
confidence: 53%
“…BCL2L12 is one of the most recently identified genes of this family, whose role in apoptosis has not been fully defined yet [35]. Although BCL2L12 expression has been found to be significantly affected by several antineoplastic drugs [36], in our experiments no remarkable alterations were noticed in its mRNA levels.…”
Section: Discussioncontrasting
confidence: 53%
“…Each PARK2 splice variants may acts in different manner to suit cell specific needs. This hypothesis is supported by previous evidences showing different and even opposite functions of other splice variants, such as BCl2L12 pattern expression related to cellular phenotype [35]. Finally, based on the extensive alternative splicing process of PARK2 gene, we cannot rule out that additional splice variants with different functions (beyond those listed) may exist.…”
Section: Park2 Alternative Splice Transcripts Produce Isoforms Witmentioning
confidence: 54%
“…Recent RNA-seq and proteomics studies have illuminated the magnitude of alternative splicing in mammals and the attendant proteomic and phenotypic diversity generated by this mechanism (Barbosa-Morais et al 2012). Different splice isoforms can have radically different functions, as for example pro-or anti-apoptotic splice variants of BCL2 (Kontos and Scorilas 2012). Limited systematic studies on dozens to hundreds of isoforms suggest that exon composition can often dramatically alter protein interaction profiles (Ellis et al 2012;Yang et al 2016).…”
Section: Evolution Of New Functionsmentioning
confidence: 99%